These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12843218

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.
    Kurland BF, Muzi M, Peterson LM, Doot RK, Wangerin KA, Mankoff DA, Linden HM, Kinahan PE.
    J Nucl Med; 2016 Feb; 57(2):226-30. PubMed ID: 26493206
    [Abstract] [Full Text] [Related]

  • 3. Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.
    Doot RK, Dunnwald LK, Schubert EK, Muzi M, Peterson LM, Kinahan PE, Kurland BF, Mankoff DA.
    J Nucl Med; 2007 Jun; 48(6):920-5. PubMed ID: 17504870
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
    Zytoon AA, Murakami K, El-Kholy MR, El-Shorbagy E, Ebied O.
    Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
    [Abstract] [Full Text] [Related]

  • 6. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
    Williams JM, Rani SD, Li X, Arlinghaus LR, Lee TC, MacDonald LR, Partridge SC, Kang H, Whisenant JG, Abramson RG, Linden HM, Kinahan PE, Yankeelov TE.
    Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Simplified kinetic analysis of tumor 18F-FDG uptake: a dynamic approach.
    Sundaram SK, Freedman NM, Carrasquillo JA, Carson JM, Whatley M, Libutti SK, Sellers D, Bacharach SL.
    J Nucl Med; 2004 Aug; 45(8):1328-33. PubMed ID: 15299057
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP, Philippens ME, Kienhorst L, Kaanders JH, Corstens FH, de Geus-Oei LF, Oyen WJ.
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [Abstract] [Full Text] [Related]

  • 13. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.
    Hickeson M, Yun M, Matthies A, Zhuang H, Adam LE, Lacorte L, Alavi A.
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1639-47. PubMed ID: 12458399
    [Abstract] [Full Text] [Related]

  • 14. Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging.
    Williams JM, Arlinghaus LR, Rani SD, Shone MD, Abramson VG, Pendyala P, Chakravarthy AB, Gorge WJ, Knowland JG, Lattanze RK, Perrin SR, Scarantino CW, Townsend DW, Abramson RG, Yankeelov TE.
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2374-2380. PubMed ID: 27557845
    [Abstract] [Full Text] [Related]

  • 15. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
    Yokoyama I, Inoue Y, Moritan T, Ohtomo K, Nagai R.
    J Nucl Med; 2003 Oct; 44(10):1592-8. PubMed ID: 14530472
    [Abstract] [Full Text] [Related]

  • 16. Standardized uptake value and quantification of metabolism for breast cancer imaging with FDG and L-[1-11C]tyrosine PET.
    Kole AC, Nieweg OE, Pruim J, Paans AM, Plukker JT, Hoekstra HJ, Schraffordt Koops H, Vaalburg W.
    J Nucl Med; 1997 May; 38(5):692-6. PubMed ID: 9170429
    [Abstract] [Full Text] [Related]

  • 17. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients.
    Schöder H, Erdi YE, Chao K, Gonen M, Larson SM, Yeung HW.
    J Nucl Med; 2004 Apr; 45(4):559-66. PubMed ID: 15073250
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of the normal adrenal gland with 18F-FDG PET/CT.
    Bagheri B, Maurer AH, Cone L, Doss M, Adler L.
    J Nucl Med; 2004 Aug; 45(8):1340-3. PubMed ID: 15299059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.